Canada Life’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Canada Life’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-577	Closed	-$12K	–	2394
2022 Q3	$12K	Buy	577 +60	+12%	+$1.62K	﹤0.01%	2327
2022 Q2	$12K	Buy	517 +62	+14%	+$2.11K	﹤0.01%	2346
2022 Q1	$23K	Buy	455 +54	+13%	+$2.67K	﹤0.01%	2330
2021 Q4	$28K	Buy	401 +51	+15%	+$4.3K	﹤0.01%	2316
2021 Q3	$33K	Hold	350	–	–	﹤0.01%	2338
2021 Q2	$35K	Hold	350	–	–	﹤0.01%	2367
2021 Q1	$32K	Hold	350	–	–	﹤0.01%	2430
2020 Q4	$29K	Buy	+350	New	+$29.8K	﹤0.01%	2469

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Canada Life's VBIV Position: Q4 2022 in Review

Canada Life sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 577 shares — an estimated $12K sold.

Canada Life first reported a position in VBIV in Q4 2020 and held it in 8 quarters. The position peaked at $35K in Q2 2021. 111 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

Canada Life reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
Canada Life sold 577 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $12K.
Canada Life first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 8 quarters.
Canada Life's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $35K in Q2 2021.
111 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.